What Dômes Pharma does

Dômes Pharma, the trading name of TVM UK Animal Health Ltd., is a privately held UK veterinary pharmaceutical company headquartered in Kirtlington, Oxfordshire. The company focuses on specialty animal health products across several niche therapeutic categories: emergency poisoning treatment (Anti-Tox Range, Carbodote Range), pet anxiety management (Tessie® for situational anxiety in dogs, Bonqat® for transport/vet-visit anxiety), ocular health (OphtaPRIME® and Remend® BioHAnce™ Corneal Gel under the Corneal Focus Range), epilepsy management (Epilepsy System), and stem cell-based regenerative treatments.

The company's business model is built on direct sales of pharmaceutical products to UK veterinary practices through a network of Territory Managers who visit clinics in person, supplemented by Lunch and Learn educational sessions. Revenue is generated through prescription and administration of these products by veterinary professionals to pet owners (end consumers). Pricing is quote-based and not publicly disclosed, consistent with a B2B veterinary distribution model. The company pairs its product portfolio with a substantial education and content ecosystem — the Vet Vault resource library, the Synaptic Tails neurology podcast, 3D Ocular Immersion tools, and sponsored CPD webinars via WebinarVet — that targets veterinary professionals as the primary decision-makers while also reaching pet owners through dedicated sites such as myepilepticpet.co.uk. The company serves a single-country UK market, with no disclosed international operations, subsidiaries, M&A activity, or institutional funding.

Name

Dômes Pharma

Legal name

TVM UK Animal Health Ltd.

Website

https://tvm-uk.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Dômes Pharma (trading as TVM UK Animal Health Ltd.) is a UK-based specialty veterinary pharmaceutical company that sells niche animal health products — including anti-toxins, anxiety treatments (Tessie®, Bonqat®), ocular care, and epilepsy and stem cell therapies — directly to veterinary practices via a Territory Manager field sales force, supported by an educational content ecosystem (Vet Vault, CPD webinars, podcasts).

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

akta.pro secondary industries

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Pet medications
• Veterinary supplies
• Companion animal care

Headquarters

HQ city

Kirtlington

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Pharmaceutical Product Sales: Dômes Pharma generates revenue through the sale of specialized veterinary pharmaceutical products across multiple therapeutic categories including anti-toxins, anxiety treatments, ocular health, and epilepsy management. Products are sold to veterinary practices who then administer or prescribe to pet owners.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Dômes Pharma develops and distributes a portfolio of specialist veterinary pharmaceutical products for companion animals across therapeutic areas including anti-poisoning, anxiety, ocular health, epilepsy management, and regenerative stem cell therapy. The company sells these products to UK veterinary practices through a direct field-sales network of Territory Managers, and supplements the product range with a comprehensive veterinary education platform (Vet Vault) including CPD webinars, podcasts, and resource libraries.

Product overview

Dômes Pharma is an innovative animal health company offering a portfolio of veterinary pharmaceutical products organized into specialist ranges. The product portfolio includes the Anxiety Range (Tessie® for situational anxiety in dogs, Bonqat® for acute anxiety during transportation/veterinary visits), Corneal Focus Range (OphtaPRIME® as a 3-in-1 ocular treatment prequel, Remend® BioHAnce™ Corneal Gel for ocular injury healing), Anti-Tox Range for poisoning cases, Carbodote Range for poisoning management, Epilepsy System for epilepsy management, and Stem Cells for advanced treatments. The company serves both veterinary professionals and pet owners, providing specialized pharmaceutical solutions across multiple therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Tessie® Veterinary pharmaceutical for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.
• Bonqat® Veterinary pharmaceutical for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in companion animals. Marketed as a newer arrival within the Anxiety Range for veterinary professionals.
• OphtaPRIME® Ocular treatment product positioned as a 3-in-1 prequel to ocular treatment within the Corneal Focus Range, for use by veterinary professionals on companion animal patients.
• Remend® BioHAnce™ Corneal Gel Ocular gel that aids the healing of ocular injuries in pets, based on BioHAnce technology. Part of the Corneal Focus Range, intended for veterinary professional use.
• Anti-Tox Range Range of veterinary pharmaceutical products designed to prepare practices for poisoning cases in companion animals. Sold to UK veterinary practices for clinical use.
• Carbodote Range Range of activated charcoal-based veterinary pharmaceutical products for the management of poisoning cases in companion animals. Sold to UK veterinary practices.
• Epilepsy System Comprehensive epilepsy management offering for pets, providing veterinary practices with a system for managing canine and feline epilepsy cases.
• Stem Cells Stem cell-based regenerative medicine treatment offering for animal health, supplied to veterinary practices as an advanced therapeutic option.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• WebinarVetcoreGTM or Marketing PartnerDômes Pharma sponsors CPD (Continuing Professional Development) content on the WebinarVet platform. The company provides sponsored webinars covering topics such as ophthalmology and stem cells, positioning the brand in front of veterinary professionals through educational content.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Elanco Animal Health: Global animal-health company with companion-animal pharmaceutical portfolio (including behavioural and dermatology products) sold to veterinary clinics; broader and deeper product set than Dômes Pharma but overlapping customer base in UK vet practices.
• Zoetis: Largest global animal-health company with deep companion-animal pharmaceutical portfolio covering dermatology, neurology and ophthalmology; significant competitor in UK vet practices and the dominant incumbent against whom all specialty pharma peers position themselves.
• Ceva Santé Animale: Global French-headquartered animal-health company with companion-animal pharmaceuticals (including neurology and behavioural products) distributed to veterinary practices worldwide; broader portfolio and global scale but overlapping specialty territory.
• Boehringer Ingelheim Animal Health: Top-3 global animal-health player with broad veterinary pharmaceutical and biological offerings distributed through vet practices; competitor in many of the same therapeutic categories (e.g. ophthalmology) and the broad-incumbent benchmark Dômes Pharma must position against.

Direct peers

• Norbrook Laboratories: Northern Ireland-based veterinary pharmaceutical manufacturer focused on companion- and production-animal medicines; directly comparable UK & Ireland specialty pharma operating with similar channel and regulatory dynamics.
• Virbac: French global veterinary pharmaceutical company with a broad companion-animal specialty portfolio (anxiety, dermatology, cardiology); closely comparable in therapeutic breadth, European footprint and veterinary-clinic go-to-market approach.
• Vetoquinol: French-listed veterinary pharmaceutical company focused on companion animals; comparable specialty/niche therapeutic portfolio (including neurology, dermatology, ophthalmology) sold to veterinary clinics with field sales teams across Europe, including the UK.
• TVM (Laboratoire TVM): Parent French veterinary pharmaceutical laboratory whose UK arm operates as 'Dômes Pharma / TVM UK Animal Health Ltd.'; same therapeutic categories, R&D pipeline, and corporate history, providing the closest product-by-product comparability.
• Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceuticals company (acquired by EQT in 2024) selling branded niche therapeutics through veterinary practices; nearly identical target customer, distribution model and therapeutic specialisation profile to Dômes Pharma's UK operations.
• Animalcare Group: UK-listed (now EQT-owned) veterinary pharmaceutical company supplying niche therapeutics to UK and European vet practices; very similar specialty-pharma positioning and product mix orientation as Dômes Pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/domespharmaUK
• Facebookfacebook.com/domespharmaUK
• LinkedInlinkedin.com/company/domes-pharma-uk

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dômes Pharma